Literature DB >> 9080476

Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody.

M Zhang1, H Sakahara, Z Yao, T Saga, Y Nakamoto, N Sato, H Nakada, I Yamashina, J Konishi.   

Abstract

In the present study, we examined the effect of avidin administered intravenously (i.v.) on the biodistribution of radiolabeled streptavidin in mice bearing intraperitoneal (IP) xenografts pretargeted with biotinylated antibody. Tumors were established in nude mice by IP inoculation of LS180 human colon cancer cells. Monoclonal antibody MLS128, which recognizes Tn antigen on mucin, was biotinylated and injected IP into the IP tumor-bearing mice. Radioiodinated streptavidin was administered IP or i.v. 48 h after pretargeting of biotinylated antibody. Avidin was administered i.v. 30 min prior to streptavidin injection. The localization of radioiodinated streptavidin in the tumor pretargeted with biotinylated antibody was significantly higher than that without pretargeting and that of radioiodinated MLS128 by the one-step method. Avidin administration significantly accelerated the clearance of radioiodinated streptavidin in blood and other normal tissues and increased the tumor-to-blood radioactivity ratio regardless of administration route of streptavidin. The i.v. avidin chase improved tumor localization of radiolabeled streptavidin in the IP xenografts pretargeted with biotinylated antibody.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9080476     DOI: 10.1016/s0969-8051(96)00162-x

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  3 in total

1.  In vivo delivery of antisense MORF oligomer by MORF/carrier streptavidin nanoparticles.

Authors:  Yi Wang; Xinrong Liu; Kayoko Nakamura; Ling Chen; Mary Rusckowski; Donald J Hnatowich
Journal:  Cancer Biother Radiopharm       Date:  2009-10       Impact factor: 3.099

2.  PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V.

Authors:  Nicole Cauchon; Réjean Langlois; Jacques A Rousseau; Guillaume Tessier; Jules Cadorette; Roger Lecomte; Darel J Hunting; Roberto A Pavan; Stefan K Zeisler; Johan E van Lier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-22       Impact factor: 9.236

3.  Construction and characterization of a truncated tissue factor‑coagulation‑based composite system for selective thrombosis in tumor blood vessels.

Authors:  Peilan Xu; Mingyuan Zou; Shengyu Wang; Tingting Li; Cong Liu; Li Wang; Lanlan Wang; Fanghong Luo; Ting Wu; Jianghua Yan
Journal:  Int J Oncol       Date:  2019-08-12       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.